The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain.

MLA

Klauke, A. L., et al. “The Cannabinoid CB₂ Receptor-Selective Phytocannabinoid Beta-Caryophyllene Exerts Analgesic Effects in Mouse Models of Inflammatory and Neuropathic Pain.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, vol. 24, no. 4, Apr. 2014, pp. 608–20. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2013.10.008.

APA

Klauke, A.-L., Racz, I., Pradier, B., Markert, A., Zimmer, A. M., Gertsch, J., & Zimmer, A. (2014). The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 24(4), 608–620. https://doi.org/10.1016/j.euroneuro.2013.10.008

Chicago

Klauke, A-L, I Racz, B Pradier, A Markert, A M Zimmer, J Gertsch, and A Zimmer. 2014. “The Cannabinoid CB₂ Receptor-Selective Phytocannabinoid Beta-Caryophyllene Exerts Analgesic Effects in Mouse Models of Inflammatory and Neuropathic Pain.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 24 (4): 608–20. doi:10.1016/j.euroneuro.2013.10.008.